Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Operating Expenses | -8,901 | 1,617 | 932 | 11,480 | 11,072 |
| Operating Income | 8,901 | -1,617 | -932 | -11,480 | -11,072 |
| Other Income | -93 | -418 | -70 | 54 | 55 |
| Pre-tax Income | 8,808 | -2,035 | -1,002 | -11,426 | -11,017 |
| Net Income Continuous | 8,808 | -2,035 | -1,002 | -11,426 | -11,017 |
| Net Income | $8,808 | $-2,035 | $-1,002 | $-11,426 | $-11,017 |
| EPS Basic Total Ops | 157.02 | -78.24 | -40.47 | -82.56 | -79.32 |
| EPS Basic Continuous Ops | 499.10 | -451.86 | -231.05 | -81.76 | -78.93 |
| EPS Diluted Total Ops | 157.02 | -78.24 | -40.47 | -82.56 | -79.32 |
| EPS Diluted Continuous Ops | 499.10 | -451.86 | -231.05 | -81.76 | -78.93 |
| EBITDA(a) | $8,920 | $-1,621 | $-1,002 | $-11,390 | $-10,978 |